Skip to main content
FMS
NYSE Industrial Applications And Services

Fresenius Medical Care Q2 Operating Income Beats Consensus by 10%, Outlook Confirmed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$25.38
Mkt Cap
$13.609B
52W Low
$20.02
52W High
$27.64
52W Position info
27% above low
Off High info
8.2% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

FMS sits 27% above its 52-week low of $20.02.

Summary

Fresenius Medical Care's Q2 2026 operating income beat consensus by 10%, with revenue also above expectations, and the company confirmed its full-year outlook.


Key Events · Earnings and Guidance · FMS

  • Q2 Operating Income Beat

    Operating income excluding special items reached €569 million, up 23% at constant currency and 10% above the €515 million consensus, driven by stronger Care Delivery growth.

  • Revenue Slightly Above Expectations

    Group revenue rose 4% at constant currency to €4,861 million, slightly above the consensus estimate of €4,792 million.

  • Full-Year Outlook Confirmed

    Management reaffirmed its unchanged financial outlook for 2026, indicating confidence in continued performance.

  • Active Buyback Program Backdrop

    The beat follows the recent launch of a new €1 billion share buyback program and cancellation of 8.5% of outstanding shares, underscoring management's commitment to shareholder returns.


Analysis · FMS · Industrial Applications And Services

Preliminary Q2 2026 results from Fresenius Medical Care show operating income excluding special items of €569 million, a 10% beat over the €515 million consensus, fueled by stronger Care Delivery performance. Revenue of €4.86 billion also edged past expectations. The company confirmed its full-year 2026 outlook, signaling confidence in sustained momentum. For a €13.6 billion company, this beat is material and arrives alongside an active €1 billion buyback program, reinforcing the positive operational trajectory.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FMS was trading at $25.38 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $13.6B. The 52-week trading range was $20.02 to $27.64. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FMS - Latest Insights

FMS
Nov 13, 2026, 3:26 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $22.06
Real-time Price: $20.55 info
Change: -$1.51 (-7%) info
Market Cap: $10.698B info
FMS
Nov 03, 2026, 8:04 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $23.02
Real-time Price: $20.55 info
Change: -$2.47 (-11%) info
Market Cap: $10.698B info
FMS
Oct 07, 2026, 12:03 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $20.89
Real-time Price: $20.55 info
Change: -$0.340 (-2%) info
Market Cap: $10.698B info
FMS
Sep 29, 2026, 11:01 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $22.12
Real-time Price: $20.55 info
Change: -$1.56 (-7%) info
Market Cap: $10.698B info
FMS
Sep 25, 2026, 7:54 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $22.42
Real-time Price: $20.55 info
Change: -$1.87 (-8%) info
Market Cap: $10.698B info